Company
Eisai Co., Ltd
Date Established
06-Dec-41
Head Office
4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
Telephone
81-3-3817-3700
Representatives
  • Haruo Naito,
    Representative Corporate Officer and CEO
  • Hideki Hayashi,
    Representative Corporate Officer, Japan Business and CIO
  • Yasushi Okada,
    Representative Corporate Officer, CTO, Industry Affairs and China Business
Capital
44,986 million Yen (as of March 31, 2017)

Scope of Business
  • Research and development, manufacture, sale and import and export of pharmaceuticals
Employees
  • Consolidated : 10,452
  • Non-Consolidated : 3,246 (as of March 31, 2017)
Production Plants
  • Kawashima Plant (Gifu Prefecture)
  • Kashima Business Office (Ibaraki Prefecture)
  • Eisai Manufacturing Ltd. (U.K.)
  • Eisai China Inc. Suzhou Plant (China)
  • Eisai (Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China)
  • Eisai Pharmaceuticals India Pvt. Ltd. (India), etc.
Laboratories
  • Tsukuba Research Laboratories (Ibaraki Prefecture)
  • Kawashima Laboratory (Gifu Prefecture)
  • KAN Research Institute, Inc. (Hyogo Prefecture)
  • Eisai Inc. Andover Research Institute (U.S.A.)
  • Morphotek, Inc. (U.S.A.)
  • H3 Biomedicine Inc. (U.S.A.)
  • Eisai Ltd. Hatfield Research Institute (U.K.), etc
Overseas Sales
Offices
  • Eisai Inc. (U.S.A.)
  • Eisai Ltd. (U.K.)
  • Eisai GmbH (Germany)
  • Eisai S.A.S. (France)
  • Eisai China Inc. (China)
  • Eisai Korea Inc. (South Korea), etc.
맨위로